Status
Conditions
About
STUDY TYPE:
Prospective, national , multicenter, and observational study.
OBJECTIVE:
To assess the incidence of AF in patients with cryptogenic stroke who have implanted an AF detection device during a period of 2 years.
DEVICE:
Reveal XT 9529 (SQDM)
SAMPLE SIZE AND STUDY DURATION:
100 patients enrolled which will be followed during a period of 2 years.
Full description
Observational study in patients with cryptogenic stroke (TOAST criteria) and with an implanted EKG loop recorder, with the primary objective of knowing the atrial fibrillation incidence in this population
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
All patients included must meet one of these two conditions:
All patients must meet all of the following:
Exclusion criteria
All patients included cannot meet any of the following conditions:
100 participants in 1 patient group
Loading...
Central trial contact
Ricardo Ruiz-Granell, MD, PhD; Arcadio García-Alberola, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal